Fluoxetine is a 2nd generation antidepressant categorized as a selective serotonin reuptake inhibitor (SSRI). It gained FDA approval in 1987 and although it was initially intended for the treatment of depression, today it is commonly prescribed to manage depression in addition to various other pathologies.
Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present. Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar ...
Mount Horeb Prayer Centre, Mamfe, Ghana
Cairo University Hospitals, Cairo, Egypt
BeniSuef University hospitals, BeniSuef, Egypt
BeniSuef University hospitals, BeniSuef, Egypt
Cairo University Hospitals, Cairo, Egypt
Tianjin Academy of Tradional Chinese Medicine Afflicated Hospital, Tianjin, Tianjin, China
First Affiliated hospital of Tianjin University of TCM, Tianjin, Tianjin, China
Beijing Hospital of Traditional Chinese Medicine, Beijing, China
New York State Psychiatric Institute/Columbia University Medical Center, New York, New York, United States
Innovative Clinical Research, Inc., Lauderhill, Florida, United States
Professional Psychiatric Services, Mason, Ohio, United States
Carilion Medical Center, Roanoke, Virginia, United States
Cairo university hospitals, Cairo, Egypt
Mayo Clinic, Rochester, Minnesota, United States
Bezirkskrankenhaus Augsburg, Augsburg, Germany
Krankenhaus Hedwigshöhe, Berlin, Germany
Hannover Medical School, Hannover, Germany
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.